HealthEquity, Inc. (NASDAQ:HQY) Shares Purchased by Fmr LLC

FMR LLC lifted its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 2.4% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,415,800 shares of the company's stock after purchasing an additional 125,684 shares during the quarter. FMR LLC owned about 6.25% of HealthEquity worth $519,646,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. Wealthfront Advisers LLC bought a new stake in shares of HealthEquity during the 4th quarter worth approximately $10,304,089,000. Norges Bank bought a new stake in shares of HealthEquity during the fourth quarter valued at approximately $74,701,000. Raymond James Financial Inc. bought a new position in shares of HealthEquity during the 4th quarter worth $45,728,000. Artisan Partners Limited Partnership purchased a new position in shares of HealthEquity during the fourth quarter valued at $24,568,000. Finally, Geneva Capital Management LLC lifted its stake in HealthEquity by 24.6% in the fourth quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company's stock worth $100,642,000 after acquiring an additional 206,894 shares during the period. Institutional investors own 99.55% of the company's stock.

HealthEquity Trading Up 0.5 %

Shares of HQY traded up $0.43 during trading on Tuesday, reaching $83.79. 170,490 shares of the company traded hands, compared to its average volume of 759,039. The stock has a 50-day simple moving average of $97.05 and a 200-day simple moving average of $96.45. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The stock has a market cap of $7.25 billion, a PE ratio of 76.87, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49.

Remove Ads

Insiders Place Their Bets

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction that occurred on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the transaction, the director now owns 84,969 shares of the company's stock, valued at $6,597,842.85. This trade represents a 6.34 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now owns 56,655 shares in the company, valued at approximately $4,433,820.30. The trade was a 13.55 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 20,381 shares of company stock worth $1,781,432 over the last ninety days. Corporate insiders own 2.20% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on HQY. KeyCorp cut their price target on HealthEquity from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Monday, March 24th. Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and reduced their price target for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. The Goldman Sachs Group dropped their target price on HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research note on Thursday, March 27th. Wells Fargo & Company boosted their price target on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. Finally, Barrington Research restated an "outperform" rating and set a $112.00 price target on shares of HealthEquity in a research note on Friday. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, HealthEquity has an average rating of "Buy" and an average price target of $112.58.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.